You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intranasal esketamine

Showing 1 - 25 of 1,119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anxiety Trial in Wenzhou (Midazolam, Esketamine, midazolam and esketamine)

Recruiting
  • Anxiety
  • Wenzhou, Zhejiang, China
    The Second Affiliated Hospital of Wenzhou Medical University
Jun 21, 2023

Treatment Resistant MDD Trial (Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine))

Recruiting
  • Treatment Resistant Major Depressive Disorder
  • Psychotherapy
  • +2 more
  • Edmonton, Alberta, Canada
    City Center Pharmacy and Medical Clinic
Nov 9, 2022

Cancer Pain Trial in Basel (esketamine nasal spray, nasal spray)

Not yet recruiting
  • Cancer Pain
  • esketamine nasal spray
  • placebo nasal spray
  • Basel, Switzerland
    University Hospital Basel, Klinik für Mund-, Kiefer- und Gesicht
Mar 3, 2022

Treatment Resistant MDD Trial (Almond Therapy, Intranasal ketamine (Esketamine), Treatment as Usual)

Not yet recruiting
  • Treatment Resistant Major Depressive Disorder
  • Almond Therapy
  • +2 more
  • (no location specified)
Jun 24, 2022

Intranasal Esketamine to Maintain Antidepressant Response to IV

Completed
  • Treatment Resistant Depression
  • Intranasal esketamine
  • Marietta, Georgia
    PsychAtlanta
Apr 19, 2021

Ketamine Treatment Trial in Vienna (56mg esketamine (2x Spravato® 28 mg nasal spray), 0.9% saline solution nasal spray)

Recruiting
  • Ketamine Treatment
  • 56mg esketamine (2x Spravato® 28 mg nasal spray)
  • 0.9% saline solution nasal spray
  • Vienna, Austria
    Department of Psychiatry and Psychotherapy
Jul 14, 2022

Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Depressive Disorder, Treatment-Resistant
  • San Diego, California
  • +68 more
Sep 2, 2021

Depression Trial in Japan (Placebo, Intranasal esketamine (28 mg), Intranasal esketamine (56 mg))

Completed
Has Results
  • Depression
  • Placebo
  • +3 more
  • Akita, Japan
  • +45 more
Sep 24, 2020

Depressive Disorder, Major Trial in Worldwide (Intranasal Placebo, Midazolam Placebo Solution, Midazolam)

Recruiting
  • Depressive Disorder, Major
  • Intranasal Placebo
  • +3 more
  • Panorama City, California
  • +65 more
Aug 17, 2022

Treatment Resistant Depressive Disorder Trial in Belgium, Japan, United States (Esketamine 14 mg, Esketamine 28 mg, Esketamine

Completed
Has Results
  • Treatment Resistant Depressive Disorder
  • Esketamine 14 mg
  • +4 more
  • Birmingham, Alabama
  • +24 more
May 18, 2020

MDD Trial in St Leonards (Esketamine Nasal Spray [Spravato])

Not yet recruiting
  • Major Depressive Disorder
  • Esketamine Nasal Spray [Spravato]
  • St Leonards, New South Wales, Australia
    Royal North Shore Hospital
Oct 22, 2023

Depressive Disorder, Major Trial in Worldwide (Esketamine, Placebo, Standard of Care)

Completed
Has Results
  • Depressive Disorder, Major
  • San Diego, California
  • +60 more
Aug 26, 2021

MDD Trial in United States (Esketamine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +13 more
May 7, 2020

MDD Trial (Ketamine, Esketamine)

Recruiting
  • Major Depressive Disorder
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 20, 2023

Treatment Resistant Depression, MDD Trial in Innsbruck (Esketamine nasal spray, Electroconvulsive therapy)

Withdrawn
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Esketamine nasal spray
  • Electroconvulsive therapy
  • Innsbruck, Tyrol, Austria
    Medical University Innsbruck
Aug 2, 2022

Acute Pain Due to Trauma Trial in Hyvinkää (Esketamine, Fentanyl Citrate, Saline Nasal)

Recruiting
  • Acute Pain Due to Trauma
  • Hyvinkää, Finland
    Hyvinkää Hospital
Feb 11, 2020

Acute Pain Due to Trauma, Analgesia Trial (Fentanyl Citrate, Esketamine)

Not yet recruiting
  • Acute Pain Due to Trauma
  • Analgesia
  • (no location specified)
Sep 20, 2023

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +49 more
May 18, 2020

Depression Trial in Mexico (Esketamine)

Recruiting
  • Depression
  • Cdmx, Mexico
  • +9 more
Aug 17, 2022

Treatment-resistant Depression Trial in Worldwide (Esketamine (Intranasal Spray), Duloxetine (Oral Antidepressant), Escitalopram

Completed
Has Results
  • Treatment-resistant Depression
  • Esketamine (Intranasal Spray)
  • +4 more
  • New Haven, Connecticut
  • +109 more
Apr 27, 2020

Breast Cancer, Perioperative Period, Dexmedetomidine Trial (Dexmedetomidine, Esketamine, Normal saline)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Feb 7, 2023

Depressive Disorder, Major Trial in Worldwide (Esketamine, Placebo, Standard of Care)

Completed
Has Results
  • Depressive Disorder, Major
  • Birmingham, Alabama
  • +55 more
Oct 8, 2020

Liver Cancer, Radiofrequency Ablation, Esketamine Trial in Beijing (Dexmedetomidine-esketamine combination, Remifentanil,

Not yet recruiting
  • Liver Cancer
  • +3 more
  • Dexmedetomidine-esketamine combination
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital
Aug 19, 2023

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +90 more
Apr 17, 2020

Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine)

Not yet recruiting
  • Scoliosis Correction
  • +4 more
  • Beijing, Beijing, China
    Beijing University First Hospital
Oct 17, 2023